FoldRx And Cystic Fibrosis Foundation Therapeutics Announce 22 Million Dollars Collaboration
FoldRx Pharmaceuticals, Inc. (FoldRx) and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit affiliate of the Cystic Fibrosis Foundation, announced that FoldRx will receive up to 22 million dollars over five years to discover and develop new compounds aimed at treating a core defect in cystic fibrosis.
